222 related articles for article (PubMed ID: 26033810)
1. Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study.
Hultcrantz M; Wilkes SR; Kristinsson SY; Andersson TM; Derolf ÅR; Eloranta S; Samuelsson J; Landgren O; Dickman PW; Lambert PC; Björkholm M
J Clin Oncol; 2015 Jul; 33(20):2288-95. PubMed ID: 26033810
[TBL] [Abstract][Full Text] [Related]
2. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
3. Excess mortality and cardiovascular events in patients surviving subarachnoid hemorrhage: a nationwide study in Sweden.
Nieuwkamp DJ; Algra A; Blomqvist P; Adami J; Buskens E; Koffijberg H; Rinkel GJ
Stroke; 2011 Apr; 42(4):902-7. PubMed ID: 21330628
[TBL] [Abstract][Full Text] [Related]
4. Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study.
Hultcrantz M; Björkholm M; Dickman PW; Landgren O; Derolf ÅR; Kristinsson SY; Andersson TML
Ann Intern Med; 2018 Mar; 168(5):317-325. PubMed ID: 29335713
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.
Chow EJ; Cushing-Haugen KL; Cheng GS; Boeckh M; Khera N; Lee SJ; Leisenring WM; Martin PJ; Mueller BA; Schwartz SM; Baker KS
J Clin Oncol; 2017 Jan; 35(3):306-313. PubMed ID: 27870568
[TBL] [Abstract][Full Text] [Related]
6. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
7. Excess Mortality among Persons with Type 2 Diabetes.
Tancredi M; Rosengren A; Svensson AM; Kosiborod M; Pivodic A; Gudbjörnsdottir S; Wedel H; Clements M; Dahlqvist S; Lind M
N Engl J Med; 2015 Oct; 373(18):1720-32. PubMed ID: 26510021
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis.
Pettersson H; Knutsen H; Holmberg E; Andréasson B
Eur J Haematol; 2015 Feb; 94(2):152-6. PubMed ID: 25039361
[TBL] [Abstract][Full Text] [Related]
9. Recent decline in the U.S. death rate from myeloproliferative neoplasms, 1999-2006.
Polednak AP
Cancer Epidemiol; 2012 Apr; 36(2):133-6. PubMed ID: 21846594
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006).
Eloranta S; Lambert PC; Sjöberg J; Andersson TM; Björkholm M; Dickman PW
J Clin Oncol; 2013 Apr; 31(11):1435-41. PubMed ID: 23439756
[TBL] [Abstract][Full Text] [Related]
11. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
[TBL] [Abstract][Full Text] [Related]
12. Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients.
Landtblom AR; Bower H; Andersson TM; Dickman PW; Samuelsson J; Björkholm M; Kristinsson SY; Hultcrantz M
Leukemia; 2018 Oct; 32(10):2203-2210. PubMed ID: 29535425
[TBL] [Abstract][Full Text] [Related]
13. US death rates from myeloproliferative neoplasms, and implications for cancer surveillance.
Polednak AP
J Registry Manag; 2011; 38(2):87-92. PubMed ID: 22096879
[TBL] [Abstract][Full Text] [Related]
14. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
[TBL] [Abstract][Full Text] [Related]
15. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
16. Cause-specific mortality among patients with psychosis: disentangling the effects of age and illness duration.
Termorshuizen F; Wierdsma AI; Smeets HM; Visser E; Drukker M; Nijman H; Sytema S
Psychosomatics; 2013; 54(6):536-45. PubMed ID: 24012288
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
18. Risk of cardiovascular events and death in the life after aneurysmal subarachnoid haemorrhage: a nationwide study.
Nieuwkamp DJ; Vaartjes I; Algra A; Rinkel GJ; Bots ML
Int J Stroke; 2014 Dec; 9(8):1090-6. PubMed ID: 22973950
[TBL] [Abstract][Full Text] [Related]
19. Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.
Hultcrantz M; Kristinsson SY; Andersson TM; Landgren O; Eloranta S; Derolf AR; Dickman PW; Björkholm M
J Clin Oncol; 2012 Aug; 30(24):2995-3001. PubMed ID: 22802311
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
Björnådal L; Yin L; Granath F; Klareskog L; Ekbom A
J Rheumatol; 2004 Apr; 31(4):713-9. PubMed ID: 15088296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
